Prevalence of smoking, alcohol and substance use among adolescents with attention-deficit/hyperactivity disorder in Denmark compared with the general population

References

• Mathews CA, Grados MA. Familiality of Tourette syndrome, obsessive–compulsive disorder, and attention-deficit/hyperactivity disorder: Heritability analysis in a large sib-pair sample. J Am Acad Child Adolesc Psychiatry 2011;50:46–54.
   PubMed Web of Science ®Google Scholar
• Franke B, Neale B, Faraone S. Genome-wide association studies in ADHD. Human Genetics 2009;126:13–50.
   PubMed Web of Science ®Google Scholar
• Curatolo P, D’Agati E, Moavero R. The neurobiological basis of ADHD. Ital J Pediatr 2010;36:79.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition (DSM-IV). Washington, D.C.: APA; 1994. p. 83–4.
   Google Scholar
• Williams C, Wright B, Partridge I. Attention deficit hyperactivity disorder–A review. Br J Gen Pract 1999;49:563–71.
   PubMed Web of Science ®Google Scholar
• Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry 2007;164:942–8.
   PubMed Web of Science ®Google Scholar
• Thapar AK, Thapar A. Attention-deficit hyperactivity disorder. Br J Gen Pract 2003;53:225–30.
   PubMed Web of Science ®Google Scholar
• Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult outcome of hyperactive children: Adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 2006;45: 192–202.
   PubMed Web of Science ®Google Scholar
• Wilens TE. The nature of the relationship between attention- deficit/hyperactivity disorder and substance use. J Clin Psychiatry 2007;68 Suppl 11:4–8.
   PubMed Web of Science ®Google Scholar
• Wilens TE. Attention-deficit/hyperactivity disorder and the substance use disorders: The nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin. North Am 2004;27:283–301.
   PubMed Web of Science ®Google Scholar
• Upadhyaya HP. Substance use disorders in children and adolescents with attention-deficit/hyperactivity disorder: Implications for treatment and the role of the primary care physician. Prim Care Companion J Clin Psychiatry 2008;10:211–21.
   PubMedGoogle Scholar
• Wilens TE, Upadhyaya HP. Impact of substance use disorder on ADHD and its treatment. J Clin Psychiatry 2007;68:e20.
   PubMedGoogle Scholar
• Wilens TE, Adamson J, Sgambati S, Whitley J, Santry A, Monuteaux MC, et al. Do individuals with ADHD self-medicate with cigarettes and substances of abuse?. >Results from a controlled family study of ADHD. Am J Addict 2007;16 Suppl 1:14–21; quiz 22–23.
   PubMed Web of Science ®Google Scholar
• Dalsgaard S, Mortensen PB, Frydenberg M, Thomsen PH. Conduct problems, gender and adult psychiatric outcome of children with attention-deficit hyperactivity disorder. Br J Psychiatry 2002;181: 416–21.
   PubMed Web of Science ®Google Scholar
• Barkley RA, Fischer M, Smallish L, Fletcher K. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics 2003;111: 97–109.
   PubMed Web of Science ®Google Scholar
• Molina BSG, Flory K, Hinshaw SP, Greiner AR, Arnold LE, Swanson JM, et al. Delinquent behavior and emerging substance use in the MTA at 36 months: Prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry 2007;46:1028–40.
   PubMed Web of Science ®Google Scholar
• Mannuzza S, Klein RG, Truong NL, Moulton JL 3rd, Roizen ER, Howell KH, et al. Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: Prospective follow-up into adulthood. Am J Psychiatry 2008;165:604–9.
   PubMed Web of Science ®Google Scholar
• Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999;104:e20.
   PubMed Web of Science ®Google Scholar
• Katusic SK, Barbaresi WJ, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/ hyperactivity disorder: A population-based, birth cohort study. J Child Adolesc Psychopharmacol 2005;15:764–76.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Adamson J, Monuteaux MC, Faraone SV, Schillinger M, Westerberg D, et al. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med 2008;162:916–21.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse?A meta-analytic review of the literature. Pediatrics 2003;111:179–85.
   Google Scholar
• Danish Ministry of Education. Number of students in schools 2007/2008 [Elevtal for grundskolen 2007/08]. UNI-C Statistik– Analyse 2008;6:1–9.
   Google Scholar
• Danish Ministry of Education. Grades in different schools in Denmark. 2008 [Karakterer per skole. 2008]. http://www.uvm.dk/service/Statistik/Folkeskolen%20og%20frie%20skoler/Elever/Karakterer.aspx 2009 [cited 18 April 2009].
   Google Scholar
• Danish Ministry of Education. Enrolment in the 9th and 10th grade . [Tilmelding til ungdomsuddannelserne for 9. og 10. klasse (FTU)]. http://www.uvm.dk/service/Statistik/Folkeskolen%20og%20frie%20skoler/Elever/Karakterer.aspx 2009. [cited 23 April 2009].
   Google Scholar
• Statens Institut for Folkesundhed. Report on public health 2007 [Folkesundhedsrapporten]. Mette Kjøller KJoFK-J, editor. Copenhagen: University of Southern Denmark; 2007.
   Google Scholar
• Goodman R. Psychometric properties of the Strengths and Difficulties Questionnaire. J Am Acad Child Adolesc Psychiatry 2001;40:1337–45.
   PubMed Web of Science ®Google Scholar
• Obel C, Dalsgaard S, Stax H-P, Bilenberg N. [Strengths and Difficulties Questionnaire (SDQ-Dan). A new instrument for psychopathologic screening of children aged 4–16 years]. Ugeskr Laeg 2003;165:462–5.
   PubMedGoogle Scholar
• Bell GH, Novak AJ, Griffin WC 3rd, Patrick KS. Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: Transesterification to ethylphenidate and elevation of d-methylphenidate concentrations. J Pharm Sci 2011;100:2966–78.
   PubMed Web of Science ®Google Scholar
• Patrick KS, Straughn AB, Minhinnett RR, Yeatts SD, Herrin AE, DeVane CL, et al. Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clin Pharmacol. Ther 2007;81:346–53.
   PubMed Web of Science ®Google Scholar